暫無數據
代碼股票名稱
最新價漲跌額漲跌幅成交量成交額今開昨收最高最低總市值流通市值總股本流通股本5日漲跌幅10日漲跌幅20日漲跌幅60日漲跌幅120日漲跌幅250日漲跌幅年初至今漲跌幅股息率TTM換手率市盈率TTM市盈率(靜)振幅所屬行業
美股期權個股詳情
GRFS240517C10000
- 0.08
- 0.000.00%
延時15分鐘行情收盤價 05/17 15:59 (美東)
0.00最高價0.00最低價
0.08今開0.08昨收0張成交量926張未平倉合約數10.00行權價0.00成交額2519.20%引伸波幅30.91%溢價2024/05/17到期日0.00内在价值100合約乘數-2天距到期日0.08時間價值100合約規模美式期權類型0.1151Delta0.1255Gamma96.25槓桿倍數-6.3468Theta0.0000Rho11.08有效槓桿0.0001Vega
分時
- 5日
- 日K
新聞
由於美國存託憑證在週五交易中小幅上漲，歐洲股市在美國交易
週五上午晚些時候，由於美國存託憑證小幅走高，歐洲股市在美國交易，標普歐洲精選ADR指數上漲0.29％，至1,426.43。索引設置爲 c
6-K：外國發行人報告（業績相關）
快訊 | Grifols董事長格蘭茲曼表示首席財務官阿爾弗雷多·阿羅約將辭職；Grifols董事長將不再擔任執行職務
基立福董事會主席Glanzmann表示：公司首席財務官（CFO） Alfredo Arroyo將離職
基立福董事會主席Glanzmann表示，公司首席財務官（CFO） Alfredo Arroyo將離職。（文章來源：財聯社）
快訊 | Grifols第一季度淨收入爲16.3億歐元，同比爲15.6億歐元；預計第一季度研發淨投資爲負9,050萬歐元，同比下降（1.047億歐元）；鑑於多項正在進行的舉措，目前正在努力改善FCF指導；將舉辦投資者和分析師日...
快訊 | Grifols有望達到財年指導並減少債務
評論
$基立福(GRFS.US$ Notorious Short seller GOTHAM spread FUD and crashes price a few weeks back! And then others keep posting the hit piece! But you hardly see any stories that GRIFOLS has filed a lawsuit against GOTHAM for that accusation! Grrrr! Well here GOTHAM, take this! Not great but good start! At least IMO! (((((((((. Grifols Q1 Net Revenues €1.63 Billion Vs €1.56 Billion YoY; Sees Q1 R&D Negative Net Investment €90.5 M...
$基立福(GRFS.US$ MT Newswires· 3 mins ago
Grifols (GRF.MC) said Monday that the sale of its 20% stake in blood products company Shanghai RAAS to Chinese home appliance company Haier Group is expected to be completed by June.
The Spanish pharmaceutical company said both the buyer and seller secured the necessary domestic and overseas government approvals for the deal. It noted that the transaction still requires a compliance confirmation from the Shenzhen Stock Exchange.
Grifols (GRF.MC) said Monday that the sale of its 20% stake in blood products company Shanghai RAAS to Chinese home appliance company Haier Group is expected to be completed by June.
The Spanish pharmaceutical company said both the buyer and seller secured the necessary domestic and overseas government approvals for the deal. It noted that the transaction still requires a compliance confirmation from the Shenzhen Stock Exchange.
$基立福(GRFS.US$ April 22, 2024 Grifols achieves positive results from phase 4 study of Fanhdi® (double-inactivated human anti-hemophilic factor) in patients with von Willebrand Disease Download PDF Grifols’ Fanhdi showed it could be effective, safe and well tolerated in the management of bleeding episodes and for the prevention of bleeding during surgeries in patients with von Willebrand Disease (VWD) VWD, which is caused by a deficiency of von Willebrand factor in plasma, is the most common ...
$基立福(GRFS.US$ Grifols (GRF.MC) is set to launch a private offering of 1 billion euros of 7.5% senior secured notes due April 2030 for the redemption of senior unsecured notes due May 2025.
The Spanish pharmaceutical group said Tuesday the note offering is contingent upon the fulfillment of customary closing conditions.
The Spanish pharmaceutical group said Tuesday the note offering is contingent upon the fulfillment of customary closing conditions.
$基立福(GRFS.US$ International Medical Industries, Inc. Announces Partnership With Grifols for Enhanced Medication Safety!!! ((((( guess it may take some time to sink in ))))) Hehehe![]()
2
閱讀更多